INTRACORONARY ADMINISTRATION OF THE ALPHA(1)-RECEPTOR AGONIST, METHOXAMINE, DOES NOT REPRODUCE THE INFARCT-LIMITING EFFECT OF ISCHEMIC PRECONDITIONING IN DOGS
L. Sebbag et al., INTRACORONARY ADMINISTRATION OF THE ALPHA(1)-RECEPTOR AGONIST, METHOXAMINE, DOES NOT REPRODUCE THE INFARCT-LIMITING EFFECT OF ISCHEMIC PRECONDITIONING IN DOGS, Cardiovascular Research, 32(5), 1996, pp. 830-838
Background: The cardioprotective effect of ischemic preconditioning ha
s been hypothesized to occur through one or more signalling mechanisms
which activate protein kinase C. Stimulation of alpha(1)-adrenergic r
eceptors by catecholamines released during the preconditioning episode
s of ischemia is one of these putative signalling mechanisms. Methods:
To determine whether stimulation of alpha(1)-adrenergic receptors bef
ore an ischemic challenge can mimic preconditioning, anesthetized dogs
were treated with 4 intracoronary infusions of methoxamine HCl (10 mu
g/kg/min; n = 8), each 5 min in duration and followed by 5 min of was
hout. Control dogs (n = 10) were given similar infusions of 0.9% NaCl.
A third group of dogs was preconditioned with 4 cycles of 5 min ische
mia, each followed by 5 min of reperfusion (n = 8). All dogs then unde
rwent 60 min of ischemia (circumflex coronary occlusion) followed by 3
h of reperfusion. Infarct size (expressed as % of area-at-risk) was m
easured with TTC macrochemistery and analyzed (using analysis of covar
iance [ANCOVA]) with respect to coronary collateral blood flow (measur
ed using radioactive microspheres). Results: Methoxamine markedly incr
eased systemic arterial and left atrial pressures prior to but not dur
ing the ischemic challenge. Baseline predictors of infarct size were n
ot different among the groups. Mean infarct size (adjusted from ANCOVA
) did not differ between control and methoxamine-treated groups, 28.3
+/- 2.8% vs. 29.7 +/- 3.2%, respectively (P = NS), but was only 12.7 /- 3.2% in the preconditioned group (P < 0.01 vs. control and methoxam
ine). Conclusions: A series of methoxamine infusions before an ischemi
c challenge did not affect infarct size. Thus, stimulation of alpha(1)
-adrenergic receptors alone is insufficient to mimic the cardioprotect
ive effect of ischemic preconditioning in this canine model.